← Leaderboards
A Kaur
Harvard University (Medical School)
$955,248
Attributed
$955,248
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$955,248 · 6
By mechanism
P51$955,248 · 6
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Ronald C Desrosiers$52,941,615
- R. Paul Johnson$56,310,063
- Andrew A Lackner$56,391,965
- W Allan Walker$22,949,174
- Keith G. Mansfield$12,495,552
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusCommunicable DiseasesImmunologyInflammationLymphatic SystemMammaliaAidsTechnology /Technique
Grant awards (9)
ANALYSIS OF CYTOTOXIC T CELL RESPONSES IN SIV INFECTED SOOTY MANGABEYS$111,112
P51 · FY2002 · RR
CMV SPECIFIC CELLULAR IMMUNITY &REACTIVATION FOLLOWING SIV INFECTION IN RHESUS$111,112
P51 · FY2002 · RR
SIVMAC239 INFECTION IN SOOTY MANGABEYS &RHESUS MACAQUES$111,112
P51 · FY2002 · RR
SIVMAC239 INFECTION IN SOOTY MANGABEYS &RHESUS MACAQUES$111,112
P51 · FY2001 · RR
CMV SPECIFIC CELLULAR IMMUNITY &REACTIVATION FOLLOWING SIV INFECTION IN RHESUS$111,112
P51 · FY2001 · RR
ANALYSIS OF CYTOTOXIC T CELL RESPONSES IN SIV INFECTED SOOTY MANGABEYS$111,112
P51 · FY2001 · RR
CMV SPECIFIC CELLULAR IMMUNITY &REACTIVATION AFTER SIV INFECTION IN MACAQUES$96,192
P51 · FY2000 · RR
IMMUNE ESCAPE EVOL IN IMMUNODOMINANT CTL EPITODE IN SIVMAC239 INFECTED MANGABEY$96,192
P51 · FY2000 · RR
MULTIPLE SIV SPECIFIC CTL EPITODES IN MANGABEYS W/ ACQUIRED SIV INFECTION$96,192
P51 · FY2000 · RR